The 2012 List of Prohibited Substances and Methods is now available
Following approval by the World Anti-Doping Agency’s (WADA) Executive Committee on September 17, the 2012 List of Prohibited Substances and Methods is now available.
Noteworthy changes to the List, which will come into force on January 1, 2012, include:
Formoterol added as an exception to beta-2 agonists
One of the most significant changes is the removal of formoterol from Section 3 ‘Beta-2 Agonists’ of the List when taken by inhalation at therapeutic dosages.
Taking into account recent research results and requests by members of the sports community, inhaled formoterol at therapeutic doses is no longer prohibited.
The List prohibits the administration of all beta-2 agonists except salbutamol (maximum 1600 micrograms over 24 hours), salmeterol when taken by inhalation, and now formoterol (maximum 36 micrograms taken over 24 hours).
The issue of beta-2 agonists will continue to be a focus of WADA’s research activity in order to ensure that the administration of large doses or by systemic routes of these substances is prevented and prohibited, but that the appropriate care and treatment of asthmatic athletes is facilitated.
In order to detect potential patterns of abuse, nicotine has been placed on WADA’s 2012 Monitoring Program.
For more information contact: info@nullwada-ama.org
To consult the 2012 Prohibited List, the 2012 Monitoring Program, a summary of modifications on the 2012 List, and a Q&A on major changes, click here.